Phase Ib/II study of the efficacy and tolerability of lenvatinib combination therapy in patients with ovarian cancer
Latest Information Update: 25 Nov 2009
At a glance
- Drugs Lenvatinib (Primary) ; Antineoplastics
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
Most Recent Events
- 25 Nov 2009 New trial record.